Pharmacology, Toxicology and Pharmaceutical Science
DOPA
100%
Parkinson's Disease
95%
Levodopa-Induced Dyskinesia
79%
Receptor
72%
Dystonia
68%
Dopamine
56%
Mouse Model
54%
Dopamine Receptor
22%
Receptor Agonist
20%
Replacement Therapy
20%
Pharmacotherapy
15%
Hypokinesia
15%
Systemic Administration
13%
Oxidopamine
13%
Antiparkinson Agent
13%
Rodent
9%
Receptor Subtype
9%
Dopamine Receptor Stimulating Agent
9%
Dopamine 1 Receptor
9%
Glutamate Receptor
9%
Heteromer
9%
Medicine and Dentistry
Patient
54%
Systemic Lupus Erythematosus
54%
Organ
54%
Observational Study
54%
Disease
20%
Bleeding
20%
Rheumatology
20%
Female
13%
Association
13%
Hazard Ratio
6%
SLEDAI
6%
Progressive Disease
6%
Proportional Hazards Model
6%
Lupus Erythematosus
6%
Neuroscience
Parkinson's Disease
69%
Dystonia
54%
L-DOPA
50%
Neuron
32%
Striatum
30%
Basal Ganglia
17%
Dyskinesia
7%